Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -229,709 | -115,519 | -73,238 | -465,892 | -406,476 |
| Depreciation Amortization | 3,912 | 1,674 | 871 | 2,785 | 1,882 |
| Accounts receivable | -59,463 | -25,409 | -7,606 | -53,822 | -30,463 |
| Accounts payable and accrued liabilities | 337 | -5,624 | -1,543 | 15,558 | 17,925 |
| Other Working Capital | 93,971 | -69,130 | -37,455 | -72,345 | -8,696 |
| Other Operating Activity | 134,859 | 78,065 | 30,080 | 118,144 | 74,742 |
| Operating Cash Flow | $-56,093 | $-135,943 | $-88,891 | $-455,572 | $-351,086 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,597 | 211,736 | 163,878 | -267,924 | -220,169 |
| PPE Investments | -857 | N/A | N/A | -1,462 | -1,267 |
| Purchase Sale Intangibles | -3,000 | 0 | 0 | -5,000 | -5,000 |
| Other Investing Activity | -3,000 | 0 | 0 | -5,000 | -5,000 |
| Investing Cash Flow | $4,740 | $211,736 | $163,878 | $-274,386 | $-226,436 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 350,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -121,664 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 28,116 | 10,381 | 8,640 | 735,062 | 715,291 |
| Other Financing Activity | -9,424 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $247,028 | $10,381 | $8,640 | $735,062 | $715,291 |
| Beginning Cash Position | 105,019 | 105,019 | 105,019 | 99,915 | 99,915 |
| End Cash Position | 300,694 | 191,193 | 188,646 | 105,019 | 237,684 |
| Net Cash Flow | $195,675 | $86,174 | $83,627 | $5,104 | $137,769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,093 | -135,943 | -88,891 | -455,572 | -351,086 |
| Capital Expenditure | -857 | 0 | 0 | -1,462 | -1,267 |
| Free Cash Flow | -56,950 | -135,943 | -88,891 | -457,034 | -352,353 |